Carregant...
A self-administered, artificial intelligence (AI) platform for cognitive assessment in multiple sclerosis (MS)
BACKGROUND: Cognitive impairment is common in patients with multiple sclerosis (MS). Accurate and repeatable measures of cognition have the potential to be used as markers of disease activity. METHODS: We developed a 5-min computerized test to measure cognitive dysfunction in patients with MS. The p...
Guardat en:
| Publicat a: | BMC Neurol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7236354/ https://ncbi.nlm.nih.gov/pubmed/32423386 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-020-01736-x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|